Literature DB >> 10338528

A conventional beagle dog model for acute and chronic infection with Helicobacter pylori.

G Rossi1, M Rossi, C G Vitali, D Fortuna, D Burroni, L Pancotto, S Capecchi, S Sozzi, G Renzoni, G Braca, G Del Giudice, R Rappuoli, P Ghiara, E Taccini.   

Abstract

Helicobacter pylori has been widely recognized as an important human pathogen responsible for chronic gastritis, peptic ulcers, gastric cancer, and mucosa-associated lymphoid tissue (MALT) lymphoma. Little is known about the natural history of this infection since patients are usually recognized as having the infection only after years or decades of chronic disease. Several animal models of H. pylori infection, including those with different species of rodents, nonhuman primates, and germ-free animals, have been developed. Here we describe a new animal model in which the clinical, pathological, microbiological, and immunological aspects of human acute and chronic infection are mimicked and which allows us to monitor these aspects of infection within the same individuals. Conventional Beagle dogs were infected orally with a mouse-adapted strain of H. pylori and monitored for up to 24 weeks. Acute infection caused vomiting and diarrhea. The acute phase was followed by polymorphonuclear cell infiltration, interleukin 8 induction, mononuclear cell recruitment, and the appearance of a specific antibody response against H. pylori. The chronic phase was characterized by gastritis, epithelial alterations, superficial erosions, and the appearance of the typical macroscopic follicles that in humans are considered possible precursors of MALT lymphoma. In conclusion, infection in this model mimics closely human infection and allows us to study those phases that cannot be studied in humans. This new model can be a unique tool for learning more about the disease and for developing strategies for treatment and prevention.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10338528      PMCID: PMC96629          DOI: 10.1128/IAI.67.6.3112-3120.1999

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  68 in total

1.  Molecular analysis of the progression from Helicobacter pylori-associated chronic gastritis to mucosa-associated lymphoid-tissue lymphoma of the stomach.

Authors:  E Zucca; F Bertoni; E Roggero; G Bosshard; G Cazzaniga; E Pedrinis; A Biondi; F Cavalli
Journal:  N Engl J Med       Date:  1998-03-19       Impact factor: 91.245

2.  The transmission of Helicobacter pylori: which theory fits the facts?

Authors:  A T Axon
Journal:  Eur J Gastroenterol Hepatol       Date:  1996-01       Impact factor: 2.566

3.  Is saliva serology useful for the diagnosis of Helicobacter pylori?

Authors:  J M Christie; C A McNulty; N A Shepherd; R M Valori
Journal:  Gut       Date:  1996-07       Impact factor: 23.059

4.  Catalase, a novel antigen for Helicobacter pylori vaccination.

Authors:  F J Radcliff; S L Hazell; T Kolesnikow; C Doidge; A Lee
Journal:  Infect Immun       Date:  1997-11       Impact factor: 3.441

5.  Therapeutic intragastric vaccination against Helicobacter pylori in mice eradicates an otherwise chronic infection and confers protection against reinfection.

Authors:  P Ghiara; M Rossi; M Marchetti; A Di Tommaso; C Vindigni; F Ciampolini; A Covacci; J L Telford; M T De Magistris; M Pizza; R Rappuoli; G Del Giudice
Journal:  Infect Immun       Date:  1997-12       Impact factor: 3.441

6.  Role of the Helicobacter pylori virulence factors vacuolating cytotoxin, CagA, and urease in a mouse model of disease.

Authors:  P Ghiara; M Marchetti; M J Blaser; M K Tummuru; T L Cover; E D Segal; L S Tompkins; R Rappuoli
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

7.  Helicobacter mustelae isolation from feces of ferrets: evidence to support fecal-oral transmission of a gastric Helicobacter.

Authors:  J G Fox; B J Paster; F E Dewhirst; N S Taylor; L L Yan; P J Macuch; L M Chmura
Journal:  Infect Immun       Date:  1992-02       Impact factor: 3.441

8.  Specific IgG1 and IgG2 antibody responses of dogs to Leishmania infantum and other parasites.

Authors:  P Deplazes; N C Smith; P Arnold; H Lutz; J Eckert
Journal:  Parasite Immunol       Date:  1995-09       Impact factor: 2.280

9.  Helicobacter pylori-induced gastritis in the domestic cat.

Authors:  J G Fox; M Batchelder; R Marini; L Yan; L Handt; X Li; B Shames; A Hayward; J Campbell; J C Murphy
Journal:  Infect Immun       Date:  1995-07       Impact factor: 3.441

10.  Protection against Helicobacter pylori infection in mice by intragastric vaccination with H. pylori antigens is achieved using a non-toxic mutant of E. coli heat-labile enterotoxin (LT) as adjuvant.

Authors:  M Marchetti; M Rossi; V Giannelli; M M Giuliani; M Pizza; S Censini; A Covacci; P Massari; C Pagliaccia; R Manetti; J L Telford; G Douce; G Dougan; R Rappuoli; P Ghiara
Journal:  Vaccine       Date:  1998-01       Impact factor: 3.641

View more
  12 in total

1.  Tyrosine phosphorylation of the Helicobacter pylori CagA antigen after cag-driven host cell translocation.

Authors:  M Stein; R Rappuoli; A Covacci
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

2.  Differences in genotypes of Helicobacter pylori from different human populations.

Authors:  D Kersulyte; A K Mukhopadhyay; B Velapatiño; W Su; Z Pan; C Garcia; V Hernandez; Y Valdez; R S Mistry; R H Gilman; Y Yuan; H Gao; T Alarcón; M López-Brea; G Balakrish Nair; A Chowdhury; S Datta; M Shirai; T Nakazawa; R Ally; I Segal; B C Wong; S K Lam; F O Olfat; T Borén; L Engstrand; O Torres; R Schneider; J E Thomas; S Czinn; D E Berg
Journal:  J Bacteriol       Date:  2000-06       Impact factor: 3.490

3.  Immunohistochemical study of lymphocyte populations infiltrating the gastric mucosa of beagle dogs experimentally infected with Helicobacter pylori.

Authors:  G Rossi; D Fortuna; L Pancotto; G Renzoni; E Taccini; P Ghiara; R Rappuoli; G Del Giudice
Journal:  Infect Immun       Date:  2000-08       Impact factor: 3.441

4.  Effects of metronidazole, tetracycline, and bismuth-metronidazole-tetracycline triple therapy in the Helicobacter pylori SS1 mouse model after 1 day of dosing: development of an H. pylori lead selection model.

Authors:  Christine F Sizemore; Joel D Quispe; Karen M Amsler; Todd C Modzelewski; Jayson J Merrill; D Andrew Stevenson; Lorie A Foster; Andrew M Slee
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

5.  What Kinds of Dogs Are Used in Clinical and Experimental Research?

Authors:  Evelyn Schulte; Sebastian P Arlt
Journal:  Animals (Basel)       Date:  2022-06-08       Impact factor: 3.231

6.  Therapeutic vaccination against Helicobacter pylori in the beagle dog experimental model: safety, immunogenicity, and efficacy.

Authors:  Giacomo Rossi; Paolo Ruggiero; Samuele Peppoloni; Laura Pancotto; Damiano Fortuna; Laura Lauretti; Gianfranco Volpini; Silvia Mancianti; Michele Corazza; Ennio Taccini; Francesco Di Pisa; Rino Rappuoli; Giuseppe Del Giudice
Journal:  Infect Immun       Date:  2004-06       Impact factor: 3.441

7.  The neutrophil-activating protein (HP-NAP) of Helicobacter pylori is a protective antigen and a major virulence factor.

Authors:  B Satin; G Del Giudice; V Della Bianca; S Dusi; C Laudanna; F Tonello; D Kelleher; R Rappuoli; C Montecucco; F Rossi
Journal:  J Exp Med       Date:  2000-05-01       Impact factor: 14.307

Review 8.  Helicobacter pylori-induced gastric pathology: insights from in vivo and ex vivo models.

Authors:  Michael D Burkitt; Carrie A Duckworth; Jonathan M Williams; D Mark Pritchard
Journal:  Dis Model Mech       Date:  2017-02-01       Impact factor: 5.758

9.  Ecological characterization of the colonic microbiota of normal and diarrheic dogs.

Authors:  Julia A Bell; Jamie J Kopper; Judy A Turnbull; Nicholas I Barbu; Alice J Murphy; Linda S Mansfield
Journal:  Interdiscip Perspect Infect Dis       Date:  2009-01-13

10.  Canine Gastric Carcinomas: A Histopathological and Immunohistochemical Study and Similarities with the Human Counterpart.

Authors:  Alexandros Hardas; Alejandro Suárez-Bonnet; Sam Beck; William E Becker; Gustavo A Ramírez; Simon L Priestnall
Journal:  Animals (Basel)       Date:  2021-05-14       Impact factor: 2.752

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.